Abstract:Background: Lung cancer remains as the leading cause of cancer-related deaths worldwide, with non-small cell carcinoma (NSCLC) being the most frequent histology (85%). Therapies that target activating EGFR mutations are NSCLC first-line treatments that improve patient life expectancy and quality of life. However, despite the current availability of novel TKI drugs in Chile and other Latin-Americans countries, little is known about the molecular epidemiology of EGFR mutations in the region. In particular, Latin… Show more
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.